194 related articles for article (PubMed ID: 17566802)
1. The cost of treating high blood pressure in general practice in France.
Tibi-Levy Y; de Pouvourville G; Westerloppe J; Bamberger M
Eur J Health Econ; 2008 Aug; 9(3):229-36. PubMed ID: 17566802
[TBL] [Abstract][Full Text] [Related]
2. The PANDORA project: results of the cost of illness analysis.
Degli Esposti E; Berto P; Ruffo P; Buda S; Degli Esposti L; Sturani A;
J Hum Hypertens; 2001 May; 15(5):329-34. PubMed ID: 11378835
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the total cost of treating elderly hypertensive patients with ACE inhibitors: a comparison of older and newer agents.
Small RE; Freeman-Arnold SB; Goode JV; Pyles MA
Pharmacotherapy; 1997; 17(5):1011-6. PubMed ID: 9324190
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of home blood pressure telemonitoring: a randomized controlled trial.
Madsen LB; Christiansen T; Kirkegaard P; Pedersen EB
Blood Press; 2011 Apr; 20(2):117-25. PubMed ID: 21105759
[TBL] [Abstract][Full Text] [Related]
5. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care?
Lorgelly P; Siatis I; Brooks A; Slinn B; Millar-Craig MW; Donnelly R; Manning G
Br J Gen Pract; 2003 Oct; 53(495):794-6. PubMed ID: 14601356
[TBL] [Abstract][Full Text] [Related]
6. [Cost of cardiovascular risk factor prevention in middle-aged French men. The PRIME study].
Marques-Vidal P; Arveiler D; Amouyel P; Ducimetière P; Ferrières J
Rev Epidemiol Sante Publique; 2001 Dec; 49(6):541-9. PubMed ID: 11845103
[TBL] [Abstract][Full Text] [Related]
7. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
[TBL] [Abstract][Full Text] [Related]
8. [Medical cost of cardiovascular risk factors prevention in France].
Marques-Vidal P; Bongard V; Arveiler D; Amouyel P; Ducimetière P; Ferrières J
Arch Mal Coeur Vaiss; 2002 Apr; 95(4):275-81. PubMed ID: 12055766
[TBL] [Abstract][Full Text] [Related]
9. The economic costs of severe anaphylaxis in France: an inquiry carried out by the Allergy Vigilance Network.
Flabbee J; Petit N; Jay N; Guénard L; Codreanu F; Mazeyrat R; Kanny G; Moneret-Vautrin DA
Allergy; 2008 Mar; 63(3):360-5. PubMed ID: 18269678
[TBL] [Abstract][Full Text] [Related]
10. [Health care too costly? Saving more than 10 million euros in 2 months!].
Rappert B
MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
[No Abstract] [Full Text] [Related]
11. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
[TBL] [Abstract][Full Text] [Related]
12. [Invasive cervical cancer treatment costs in France].
Arveux P; Bénard S; Bouée S; Lafuma A; Martin L; Cravello L; Rémy V; Breugelmans JG
Bull Cancer; 2007 Feb; 94(2):219-24. PubMed ID: 17337390
[TBL] [Abstract][Full Text] [Related]
13. [COART France 2003 report on new socioeconomic data on osteoarthritis in France].
Solignac M
Presse Med; 2004 May; 33(9 Pt 2):S4-6. PubMed ID: 15226681
[TBL] [Abstract][Full Text] [Related]
14. Cost of hypertension treatment.
Odell TW; Gregory MC
J Gen Intern Med; 1995 Dec; 10(12):686-8. PubMed ID: 8770721
[TBL] [Abstract][Full Text] [Related]
15. [Use of antihypertensive drugs in Spain (1995-2001)].
García del Pozo J; Ramos Sevillano E; de Abajo FJ; Mateos Campos R
Rev Esp Cardiol; 2004 Mar; 57(3):241-9. PubMed ID: 15056428
[TBL] [Abstract][Full Text] [Related]
16. Cost effective analyses in the treatment of high blood pressure.
Fletcher A
J Hum Hypertens; 1992 Dec; 6(6):437-45. PubMed ID: 1296007
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness of treating ocular hypertension.
Stewart WC; Stewart JA; Nasser QJ; Mychaskiw MA
Ophthalmology; 2008 Jan; 115(1):94-8. PubMed ID: 18166406
[TBL] [Abstract][Full Text] [Related]
18. Driving cost factors in adult outpatients with refractory epilepsy: a daily clinical practice in clinics of neurology in Spain.
Peña P; Sancho J; Rufo M; Martínez S; Rejas J;
Epilepsy Res; 2009 Feb; 83(2-3):133-43. PubMed ID: 19095410
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and treatment of diabetes in France: trends between 2000 and 2005.
Kusnik-Joinville O; Weill A; Salanave B; Ricordeau P; Allemand H
Diabetes Metab; 2008 Jun; 34(3):266-72. PubMed ID: 18524662
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin receptor blockers: impact on costs of care.
Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
